A world beyond borders: rethinking global oncology in 2024

Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010; 376(9747): 1186–93. doi: 10.1016/S0140-6736(10)61152-X DOI: https://doi.org/10.1016/S0140-6736(10)61152-X

Gralow JR, Asirwa FC, Bhatt AS, Bourlon MT, Chu Q, Eniu AE, et al. Recommendations from the ASCO Academic Global Oncology Task Force. JCO Glob Oncol 2020; 6: 1666–73. doi: 10.1200/GO.20.00497 DOI: https://doi.org/10.1200/GO.20.00497

LeBaron VT. Global cancer disparities and the need for new initiatives. Oncol Nurs Forum 2016; 43(1): 118–20. doi: 10.1188/16.ONF.118-120 DOI: https://doi.org/10.1188/16.ONF.118-120

Desai A, Duma N, Lopes G. COVID-19 and global oncology: a year in review. JCO Glob Oncol 2021; 7: 797–801. doi: 10.1200/GO.21.00078 DOI: https://doi.org/10.1200/GO.21.00078

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394–424. doi: 10.3322/caac.21492 DOI: https://doi.org/10.3322/caac.21492

Knaul FM, Arreola-Ornelas H, Rodriguez NM, Méndez-Carniado O, Kwete XJ, Puentes-Rosas E, et al. Avoidable mortality: the core of the global cancer divide. J Glob Oncol 2018; 4: 1–12. doi: 10.1200/JGO.17.00190 DOI: https://doi.org/10.1200/JGO.17.00190

Dos-Santos-Silva I, Gupta S, Orem J, Shulman LN. Global disparities in access to cancer care. Commun Med 2022; 2: 31. doi: 10.1038/s43856-022-00097-5 DOI: https://doi.org/10.1038/s43856-022-00097-5

Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol 2021; 18(10): 663–72. doi: 10.1038/s41571-021-00514-z DOI: https://doi.org/10.1038/s41571-021-00514-z

Blanchard C, Lubuzo B, Asirwa FC, Dlamini X, Msadabwe-Chikuni SC, Mwachiro M, et al. Multisector collaborations and global oncology: the only way forward. JCO Glob Oncol 2021; 7: 153–61. doi: 10.1200/GO.20.00492 DOI: https://doi.org/10.1200/GO.20.00492

Parker M, Kingori P. Good and bad research collaborations: researchers’ views on science and ethics in global health research. PLoS One 2016; 11(10): e0163579. doi: 10.1371/journal.pone.0163579 DOI: https://doi.org/10.1371/journal.pone.0163579

Wells JC, Sharma S, Del Paggio JC, Hopman WM, Gyawali B, Mukherji D, et al. An analysis of contemporary oncology randomized clinical trials from low/middle-income vs high-income countries. JAMA Oncol 2021; 7(3): 379–85. doi: 10.1001/jamaoncol.2020.7478 DOI: https://doi.org/10.1001/jamaoncol.2020.7478

Nazha B, Mishra M, Pentz R, Owonikoko TK. Enrollment of racial minorities in clinical trials: old problem assumes new urgency in the age of immunotherapy. Am Soc Clin Oncol 2019; 39: 3–10. doi: 10.1200/EDBK_100021 DOI: https://doi.org/10.1200/EDBK_100021

Siddiqui AH, Zafar SN. Global availability of cancer registry data. J Glob Oncol 2018; 4: 1–3. doi: 10.1200/JGO.18.00116 DOI: https://doi.org/10.1200/JGO.18.00116

Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 2019; 144(8): 1941–53. doi: 10.1002/ijc.31937 DOI: https://doi.org/10.1002/ijc.31937

Union for International Cancer Control. Available from: https://www.uicc.org/who-we-are/about-uicc/what-cancer-control [cited 25 January 2024].

World Health Organization (WHO). Available from: https://www.who.int/initiatives/the-global-initiative-for-childhood-cancer [cited 25 January 2024].